These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4254276)

  • 41. A nursing perspective of the invasive electrophysiologic approach to treatment of ventricular arrhythmias.
    Tyndall A
    Heart Lung; 1983 Nov; 12(6):620-9. PubMed ID: 6556176
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pharmacological study of (naphtyloxy-1)4-hydroxy-3 butyramidoxime chlorhydrate or LL 1530. Anti-arrhythmic action].
    Duteil J; Nadaud J; Henry M; Assous E; Gombert R
    Therapie; 1973; 28(4):703-20. PubMed ID: 4793689
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 45. The clinical pharmacology of antiarrhythmic drugs. Part II: Quinidine, propranolol, diphenylhydantoin, and bretylium.
    Levitt B; Borer JS; Sarapa A
    Cardiovasc Nurs; 1974; 10(6):27-31. PubMed ID: 4498549
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pharmacology and clinical biopharmacy of quinidine].
    Huynh-Ngoc T; Sirois G
    J Pharm Belg; 1974 Mar; 29(2):152-80. PubMed ID: 4840388
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacotherapy of cardiac arrhythmias in acute myocardial infarction.
    van Dijk L
    Folia Med Neerl; 1971; 14(5):225-36. PubMed ID: 4400908
    [No Abstract]   [Full Text] [Related]  

  • 48. Electrophysiological actions of diphenylhydantoin on rabbit atria. Dependence on stimulation frequency, potassium, and sodium.
    Jensen RA; Katzung BG
    Circ Res; 1970 Jan; 26(1):17-27. PubMed ID: 5410092
    [No Abstract]   [Full Text] [Related]  

  • 49. Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview.
    Dorian P; Newman D
    Europace; 2000 Oct; 2(4):277-85. PubMed ID: 11194593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevention and treatment of drug-induced arrhythmia in acute myocardial infarct].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1972 Oct; 27(20):875-81. PubMed ID: 4405247
    [No Abstract]   [Full Text] [Related]  

  • 51. [Arrhythmias and heart failure].
    Amann FW; Candinas R
    Ther Umsch; 1993 Jun; 50(6):419-24. PubMed ID: 8351673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His].
    Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G
    Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451
    [No Abstract]   [Full Text] [Related]  

  • 53. [Arrhythmogenic effects of anti-arrhythmia drugs].
    Popławska W
    Pol Arch Med Wewn; 1991 Aug; 86(2):61-4. PubMed ID: 1775391
    [No Abstract]   [Full Text] [Related]  

  • 54. [Harmful interactions of amiodarone and class I anti-arrhythmia agents].
    Tartini R; Kappenberger L; Steinbrunn W
    Schweiz Med Wochenschr; 1982 Nov; 112(45):1585-7. PubMed ID: 7156952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 56. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

  • 57. The experimental basis for the choice of an anti-arrhythmic drug.
    Vaughan Williams EM
    Adv Cardiol; 1970; 4():275-89. PubMed ID: 4395423
    [No Abstract]   [Full Text] [Related]  

  • 58. [Arrhythmia. 8. Quinidine for the maintenance of the sinus rhythm after regularization].
    Cramér G
    Lakartidningen; 1971 Jun; 68():Suppl II:110-. PubMed ID: 5113222
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessment of antiarrhythmic drugs in experimental pharmacology.
    Caillard CG; Louis JC
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586
    [No Abstract]   [Full Text] [Related]  

  • 60. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
    Nattel S
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.